Search - tctmd.com

Displaying 341 - 360 of 1588

Sort: Relevancy | Date

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

Presenter: Andrew Kaplan

October 24, 2023

Presentation TCT 2023

TCT 292: Regional Disparity of the Bypass Strategy and Graft Patent Rate in the Fast-in-man Trial of Coronary Surgical Revascularization Solely Guided on Multislice Computed Tomography

Presenter: SHIGETAKA KAGEYAMA

October 24, 2023

Presentation TCT 2023

Perspectives on Mortality in the PARNTER 5-Year Study

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

Presenter: Roberto Galea

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

The Future of Clinical Data for The Reducer

Presenter: Megha Prasad

October 24, 2023

TCT 669: Impact of ACS on Long-Term Clinical Outcomes After PCI With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presentation TCT 2023

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Presenter: Manijeh Noori

October 24, 2023

Presentation TCT 2023

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

Presenter: Jason Rogers

October 24, 2023

Presentation TCT 2023

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Presenter: Anna van Veelen

October 24, 2023

Presentation TCT 2023

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Presenter: Rebecca Hahn

October 24, 2023

Presentation TCT 2023

TCT 64: Very Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon After a Bare-Metal Stent for the Treatment of ST-Elevation Myocardial Infarction: 8-Year Results of a Randomized Clinical Trial (PEBSI Study)

Presenter: Arturo Garcia-Touchard

October 24, 2023

Presentation TCT 2023

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

Presenter: R. Kevin Rogers

October 24, 2023

Presentation TCT 2023

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Presenter: Vinod Thourani

October 24, 2023

Presentation TCT 2023

TCT 670: Sub-optimal OCT-guiding and Association with Two-year Clinical Outcomes - An OCTOBER Trial Substudy

Presenter: Omeed Neghabat

October 24, 2023

TCT 600: Evaluation of the stent parameters post-PCI and its relation to post-PCI physiological outcomes: insights from the ASET JAPAN Trial

Presentation TCT 2023

TCT 600: Evaluation of the stent parameters post-PCI (minimum stent area, stent expansion index, and stent gradient) and its relation to post-PCI physiological outcomes assessed by intravascular imaging based ultrasonic flow ratio and optical flow ratio:…

Presenter: Pruthvi Chenniganahosahalli Revaiah

October 24, 2023

Presentation TCT 2023

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Presenter: Samir Kapadia

October 24, 2023

Presentation TCT 2023

Four-Year Outcomes From the EVOLUT Low Risk Trial

Presenter: Michael Reardon

October 24, 2023

Presentation TCT 2023

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Presenter: Martin Leon

October 24, 2023

Advertisement

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

TCT 253: Medication Adjustments Associated With Implantation of a Cardiac Alerting Device: The ALERTS Trial

TCT 292: Regional Disparity of the Bypass Strategy and Graft Patent Rate in the Fast-in-man Trial of Coronary Surgical Revascularization Solely Guided on Multislice Computed Tomography

Perspectives on Mortality in the PARNTER 5-Year Study

One-Year Outcomes after Amulet or Watchman/FLX Device for Percutaneous Left Atrial Appendage Closure: a Pre-Specified Analysis of the SWISS-APERO Randomized Clinical Trial

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

The Future of Clinical Data for The Reducer

TCT 669: Impact of Acute Coronary Syndromes on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With the Biolimus-Coated BioFreedom Stent or Biodegradable Polymer Sirolimus-Eluting Orsiro Stent: From the SORT OUT IX Trial

Tendyne SUMMIT Pivotal Trial Roll-In and MAC Arm Outcomes

TCT 417: Ten-Year Clinical Outcomes After Randomization to PCI of a Concurrent Chronic Total Coronary Occlusion or Optimal Medical Therapy Alone in Patients With STEMI: Extended Follow-Up of the EXPLORE Trial

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

TCT 64: Very Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon After a Bare-Metal Stent for the Treatment of ST-Elevation Myocardial Infarction: 8-Year Results of a Randomized Clinical Trial (PEBSI Study)

TCT 243: Early Risk of Major Adverse Limb Events Following Lower Extremity Revascularization in the VOYAGER-PAD Trial

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

TCT 670: Sub-optimal OCT-guiding and Association with Two-year Clinical Outcomes - An OCTOBER Trial Substudy

TCT 600: Evaluation of the stent parameters post-PCI (minimum stent area, stent expansion index, and stent gradient) and its relation to post-PCI physiological outcomes assessed by intravascular imaging based ultrasonic flow ratio and optical flow ratio:…

Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - WATCH TAVR Trial Results

Four-Year Outcomes From the EVOLUT Low Risk Trial

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content